助力国内外作者成功发表NatureScience等国际顶尖期刊!

投稿难?全流程投稿协助,直达Accept!

CSSCICSCD北大统计源知网万方维普

专注期刊投稿咨询

多年服务铸就口碑期刊服务信赖之选
免费咨询

大类学科: 不限 医学 生物 物理 化学 农林科学 数学 地学天文 地学 环境科学与生态学 综合性期刊 管理科学 社会科学 查看全部热门领域

中科院分区: 不限 1区 2区 3区 4区

期刊收录: 不限 SCI SCIE

Asian Pacific Journal of Cancer Prevention

SCI期刊查询网 更新时间:2026-04-02 00:04:45
Asian Pacific Journal of Cancer Prevention封面

简称:ASIAN PAC J CANCER P

ISSN:1513-7368

ESSN:1513-7368

所属分区:0区

出版地:JAPAN

出版周期:Quarterly

创刊时间:2000

研究方向:医学-肿瘤学

易录用期刊推荐+论文格式模板+论文快速过审指导

填写需求
联系方式
PS:专业学术顾问会及时联系解答。

Asian Pacific Journal of Cancer Prevention英文简介

Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.

The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.

The APJCP publishes original research results under the following categories:

-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.

IF值(影响因子)趋势图